Connect With Us
Commitment to Global HealthHomeOur PurposeCommitment-to-global-health Our Commitment to Global Health

Against a complex health landscape, we unleash the power of our assets – from our medicines and vaccines to our financial investments and colleagues’ expertise – to help strengthen health systems and improve access to quality healthcare services for patients around the world. 

Together with our partners, we seek to unlock transformative and sustainable solutions through our programs and investments to achieving a healthier world for everyone. 

Expanding Access

We believe that all patients should have access to the medicines they need.

Through our partnerships with global health institutions and implementation of novel price structures – including donations where appropriate – Pfizer blends philanthropy and business approaches to increase access to our medicines and vaccines where they are most needed. 

Strengthening Health Systems

Through our global health programs and partnerships, we support initiatives that strengthen overall health systems of communities in need, helping to drive progress toward the UN Sustainable Development Goals (SDGs). 

From training frontline healthcare workers and supporting infrastructure and care delivery enhancements to providing global health grants and investments, we are ensuring system capacity and sustainability to deliver desired health outcomes for the most vulnerable populations. 

For more on Pfizer’s Global Health Initiatives click here

Careers News Report an Adverse EventOur PurposeOur ScienceOur ManufacturingConnect With UsPrivacy PolicyTerms of UseCopyright © 2023 Pfizer Pakistan. All rights reserved. This information is intended for residents of Pakistan. The product information provided on the website relates to Products listed in Pakistan. These products may have different labeling in other markets. We are a subsidiary of Pfizer Inc., a pharmaceutical company committed to helping people improve their health by discovering and developing innovative medicines.
PP-UNP-PAK-0103, 2023-11